KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Treasury Shares (2020 - 2025)

Globus Medical (GMED) has disclosed Treasury Shares for 7 consecutive years, with $12000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Treasury Shares fell 82.09% year-over-year to $12000.0, compared with a TTM value of $12000.0 through Dec 2025, down 82.09%, and an annual FY2025 reading of $12000.0, down 97.12% over the prior year.
  • Treasury Shares was $12000.0 for Q4 2025 at Globus Medical, down from $3.5 million in the prior quarter.
  • Across five years, Treasury Shares topped out at $29.6 million in Q2 2024 and bottomed at $12000.0 in Q4 2025.
  • Average Treasury Shares over 5 years is $3.3 million, with a median of $2.4 million recorded in 2022.
  • The sharpest move saw Treasury Shares plummeted 97.02% in 2023, then soared 42185.71% in 2024.
  • Year by year, Treasury Shares stood at $29000.0 in 2021, then surged by 106.9% to $60000.0 in 2022, then surged by 76.67% to $106000.0 in 2023, then tumbled by 36.79% to $67000.0 in 2024, then crashed by 82.09% to $12000.0 in 2025.
  • Business Quant data shows Treasury Shares for GMED at $12000.0 in Q4 2025, $3.5 million in Q3 2025, and $2.8 million in Q2 2025.